Interference Mix 6 (For Qualitative Use

Code: I-028-1ML D2-231

General description

A multi-component solution standard of routinely monitored over-the-counter (OTC) and prescription drugs amlodipine, atorvastatin, cetirizine, azithromyci...


read more

Your Price
€376.14 1ML
€462.65 inc. VAT
REQUEST

General description

A multi-component solution standard of routinely monitored over-the-counter (OTC) and prescription drugs amlodipine, atorvastatin, cetirizine, azithromycin, bupivacaine, dimenhydrinate, lisinopril, and loratidine. This standard is for qualitative use only in the evaluation of interferences between the mix components and target analytes of interest in a testing laboratory′s analytical methods.

Legal Information

CERILLIANT is a registered trademark of Cerilliant Corporation

application(s)forensics and toxicology
compositionAmlodipine besylate, 5 µg/mL (as free base), Bupivacaine hydrochloride monohydrate, 100 µg/mL (as free base), Azithromycin dihydrate, 100 µg/mL (as free base), Cetirizine dihydrochloride, 50 µg/mL (as free base), Atorvastatin calcium salt, 100 µg/mL (as free base), Loratadine, 100 µg/mL, Lisinopril dihydrate, 100 µg/mL (as free base), Dimenhydrinate, 100 µg/mL
concentration5-100 µg/mL each component in methanol
formliquid
formatsingle component solution
gradeanalytical standard
manufacturer/tradenameCerilliant®
packagingampule of 1 mL
storage temp.−20°C
technique(s)gas chromatography (GC): suitable, liquid chromatography (LC): suitable
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.